Satellite Symposium on Challenges to Enteric Vaccines: Salvador de Bahia, Brazil, 12 June 2005

Por Steele, A.D., Kieny, M.P.
Publicado em 2007

Immunogenicity of HIV-1(LAI) gp160 and env peptides in squirrel monkey Saimiri sciureus using alumine and experimental adjuvants

Por PERRAUT, R, CHOUTEAU, P, MOOG, C, BONNEMAINS, B, KIENY, M P
Publicado em 1996

Vaccination against tumor cells expressing breast cancer epithelial tumor antigen.

Por Hareuveni, M, Gautier, C, Kieny, M P, Wreschner, D, Chambon, P, Lathe, R
Publicado em 1990

Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.

Por Fenouillet, E, Jones, I, Powell, B, Schmitt, D, Kieny, M P, Gluckman, J C
Publicado em 1993

A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein.

Por Guy, B, Geist, M, Dott, K, Spehner, D, Kieny, M P, Lecocq, J P
Publicado em 1991

Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.

Por Hadida, F, Parrot, A, Kieny, M P, Sadat-Sowti, B, Mayaud, C, Debre, P, Autran, B
Publicado em 1992

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.

Por Girard, M, Kieny, M P, Pinter, A, Barre-Sinoussi, F, Nara, P, Kolbe, H, Kusumi, K, Chaput, A, Reinhart, T, Muchmore, E
Publicado em 1991

Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins.

Por Riviere, Y, Tanneau-Salvadori, F, Regnault, A, Lopez, O, Sansonetti, P, Guy, B, Kieny, M P, Fournel, J J, Montagnier, L
Publicado em 1989

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.

Por Girard, M, Meignier, B, Barré-Sinoussi, F, Kieny, M P, Matthews, T, Muchmore, E, Nara, P L, Wei, Q, Rimsky, L, Weinhold, K
Publicado em 1995

Alteration of V3 loop context within the envelope of human immunodeficiency virus type 1 enhances neutralization.

Por Robert-Guroff, M, Louie, A, Myagkikh, M, Michaels, F, Kieny, M P, White-Scharf, M E, Potts, B, Grogg, D, Reitz, M S
Publicado em 1994

Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene.

Por Wiktor, T J, Macfarlan, R I, Reagan, K J, Dietzschold, B, Curtis, P J, Wunner, W H, Kieny, M P, Lathe, R, Lecocq, J P, Mackett, M
Publicado em 1984

Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa.

Por McCutchan, F E, Artenstein, A W, Sanders-Buell, E, Salminen, M O, Carr, J K, Mascola, J R, Yu, X F, Nelson, K E, Khamboonruang, C, Schmitt, D, Kieny, M P, McNeil, J G, Burke, D S
Publicado em 1996

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Por Agnandji, S.T., Huttner, A., Zinser, M.E., Njuguna, P., Dahlke, C., Fernandes, J.F., Yerly, S., Dayer, J.-A., Kraehling, V., Kasonta, R., Adegnika, A.A., Altfeld, M., Auderset, F., Bache, E.B., Biedenkopf, N., Borregaard, S., Brosnahan, J.S., Burrow, R., Combescure, C., Desmeules, J., Eickmann, M., Fehling, S.K., Finckh, A., Goncalves, A.R., Grobusch, M.P., Hooper, J., Jambrecina, A., Kabwende, A.L., Kaya, G., Kimani, D., Lell, B., Lemaître, B., Lohse, A.W., Massinga-Loembe, M., Matthey, A., Mordmüller, B., Nolting, A., Ogwang, C., Ramharter, M., Schmidt-Chanasit, J., Schmiedel, S., Silvera, P., Stahl, F.R., Staines, H.M., Strecker, T., Stubbe, H.C., Tsofa, B., Zaki, S., Fast, P., Moorthy, V., Kaiser, L., Krishna, S., Becker, S., Kieny, M.-P., Bejon, P., Kremsner, P.G., Addo, M.M., Siegrist, C.-A.
Publicado no N Engl J Med (2015)